ArticleBMJ open diabetes research & care2022

Comparative effect of metformin versus sulfonylureas with dementia and Parkinson's disease risk in US patients over 50 with type 2 diabetes mellitus.

Danielle Newby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.